HC
ELV icon

Hosking & Co’s Elevance Health ELV Stock Holding History

Hosking & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$6.87M Buy
41,877
+2,962
+8% +$473K 0.46% 55
2015
Q1 		$6.01M Buy
38,915
+2,767
+8% +$394K 0.43% 61
2014
Q4 		$4.54M Buy
+36,148
New +$4.47M 0.34% 74

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Hosking & Co's ELV Position: Q2 2015 in Review

Hosking & Co increased its Elevance Health (ELV) stake by 7.6% in Q2 2015, buying an estimated $473K and bringing the position to 41,877 shares worth $6.87M. The position accounts for 0.46% of the portfolio, ranked #55.

Hosking & Co first reported a position in ELV in Q4 2014 and has held it in 3 quarters since. 780 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

  • Hosking & Co held 41,877 shares of Elevance Health worth $6.87M as of Q2 2015.
  • Hosking & Co bought 2,962 Elevance Health shares in Q2 2015, an estimated $473K.
  • Elevance Health made up 0.46% of Hosking & Co's portfolio in Q2 2015, its #55 holding.
  • Hosking & Co first reported a position in Elevance Health in Q4 2014 and has held it in 3 quarters since.
  • 780 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on Hosking & Co's 13F filing for Q2 2015, filed 13 Aug 2015.